MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP

Clinical trial NCT06361108 · RECRUITING

Trial details

NCT number: NCT06361108
Sponsor: Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathic Pain

Start date: 2024-05-16
Primary completion: 2025-12-20
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.